China Neuromodulation Devices and Implantable Infusion Pumps Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Neuromodulation Devices and Implantable Infusion Pumps Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Neuromodulation Devices and Implantable Infusion Pumps Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Neuromodulation Devices and Implantable Infusion Pumps Overall Market Size
2.1 China Neuromodulation Devices and Implantable Infusion Pumps Market Size: 2021 VS 2027
2.2 China Neuromodulation Devices and Implantable Infusion Pumps Revenue, Prospects & Forecasts: 2016-2027
2.3 China Neuromodulation Devices and Implantable Infusion Pumps Sales: 2016-2027
3 Company Landscape
3.1 Top Neuromodulation Devices and Implantable Infusion Pumps Players in China Market
3.2 Top China Neuromodulation Devices and Implantable Infusion Pumps Companies Ranked by Revenue
3.3 China Neuromodulation Devices and Implantable Infusion Pumps Revenue by Companies
3.4 China Neuromodulation Devices and Implantable Infusion Pumps Sales by Companies
3.5 China Neuromodulation Devices and Implantable Infusion Pumps Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Neuromodulation Devices and Implantable Infusion Pumps Companies in China Market, by Revenue in 2020
3.7 Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neuromodulation Devices and Implantable Infusion Pumps Players in China Market
3.8.1 List of Tier 1 Neuromodulation Devices and Implantable Infusion Pumps Companies in China
3.8.2 List of Tier 2 and Tier 3 Neuromodulation Devices and Implantable Infusion Pumps Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Neuromodulation Devices and Implantable Infusion Pumps Market Size Markets, 2021 & 2027
4.1.2 Spinal Cord Stimulation
4.1.3 Deep Brain Stimulation
4.1.4 Sacral Nerve Stimulation
4.1.5 Vagal Nerve Stimulation
4.1.6 Gastric Stimulation
4.1.7 Transcranial Magnetic Stimulation
4.1.8 Transcutaneous Electrical Stimulation
4.1.9 Other
4.2 By Type - China Neuromodulation Devices and Implantable Infusion Pumps Revenue & Forecasts
4.2.1 By Type - China Neuromodulation Devices and Implantable Infusion Pumps Revenue, 2016-2021
4.2.2 By Type - China Neuromodulation Devices and Implantable Infusion Pumps Revenue, 2022-2027
4.2.3 By Type - China Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share, 2016-2027
4.3 By Type - China Neuromodulation Devices and Implantable Infusion Pumps Sales & Forecasts
4.3.1 By Type - China Neuromodulation Devices and Implantable Infusion Pumps Sales, 2016-2021
4.3.2 By Type - China Neuromodulation Devices and Implantable Infusion Pumps Sales, 2022-2027
4.3.3 By Type - China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share, 2016-2027
4.4 By Type - China Neuromodulation Devices and Implantable Infusion Pumps Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Neuromodulation Devices and Implantable Infusion Pumps Market Size, 2021 & 2027
5.1.2 Parkinson's Disease
5.1.3 Epilepsy
5.1.4 Pain
5.1.5 Other
5.2 By Application - China Neuromodulation Devices and Implantable Infusion Pumps Revenue & Forecasts
5.2.1 By Application - China Neuromodulation Devices and Implantable Infusion Pumps Revenue, 2016-2021
5.2.2 By Application - China Neuromodulation Devices and Implantable Infusion Pumps Revenue, 2022-2027
5.2.3 By Application - China Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share, 2016-2027
5.3 By Application - China Neuromodulation Devices and Implantable Infusion Pumps Sales & Forecasts
5.3.1 By Application - China Neuromodulation Devices and Implantable Infusion Pumps Sales, 2016-2021
5.3.2 By Application - China Neuromodulation Devices and Implantable Infusion Pumps Sales, 2022-2027
5.3.3 By Application - China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share, 2016-2027
5.4 By Application - China Neuromodulation Devices and Implantable Infusion Pumps Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Overview
6.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales and Revenue in China Market (2016-2021)
6.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Description
6.1.5 Medtronic Recent Developments
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Overview
6.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales and Revenue in China Market (2016-2021)
6.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Description
6.2.5 Boston Scientific Corporation Recent Developments
6.3 St. Jude Medical
6.3.1 St. Jude Medical Corporation Information
6.3.2 St. Jude Medical Overview
6.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales and Revenue in China Market (2016-2021)
6.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Description
6.3.5 St. Jude Medical Recent Developments
6.4 Synapse Biomedical
6.4.1 Synapse Biomedical Corporation Information
6.4.2 Synapse Biomedical Overview
6.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales and Revenue in China Market (2016-2021)
6.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Description
6.4.5 Synapse Biomedical Recent Developments
6.5 Nevro Corporation
6.5.1 Nevro Corporation Corporation Information
6.5.2 Nevro Corporation Overview
6.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales and Revenue in China Market (2016-2021)
6.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Description
6.5.5 Nevro Corporation Recent Developments
6.6 Neuropace
6.6.1 Neuropace Corporation Information
6.6.2 Neuropace Overview
6.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales and Revenue in China Market (2016-2021)
6.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Description
6.6.5 Neuropace Recent Developments
6.7 Cyberonics
6.7.1 Cyberonics Corporation Information
6.7.2 Cyberonics Overview
6.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales and Revenue in China Market (2016-2021)
6.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Description
6.7.5 Cyberonics Recent Developments
6.8 Autonomic Technologies
6.8.1 Autonomic Technologies Corporation Information
6.8.2 Autonomic Technologies Overview
6.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales and Revenue in China Market (2016-2021)
6.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Description
6.8.5 Autonomic Technologies Recent Developments
6.9 Avery Biomedical
6.9.1 Avery Biomedical Corporation Information
6.9.2 Avery Biomedical Overview
6.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales and Revenue in China Market (2016-2021)
6.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Description
6.9.5 Avery Biomedical Recent Developments
6.10 Greatbatch Medical
6.10.1 Greatbatch Medical Corporation Information
6.10.2 Greatbatch Medical Overview
6.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales and Revenue in China Market (2016-2021)
6.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Description
6.10.5 Greatbatch Medical Recent Developments
7 China Neuromodulation Devices and Implantable Infusion Pumps Production Capacity, Analysis
7.1 China Neuromodulation Devices and Implantable Infusion Pumps Production Capacity, 2016-2027
7.2 Neuromodulation Devices and Implantable Infusion Pumps Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Neuromodulation Devices and Implantable Infusion Pumps Supply Chain Analysis
9.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Value Chain
9.2 Neuromodulation Devices and Implantable Infusion Pumps Upstream Market
9.3 Neuromodulation Devices and Implantable Infusion Pumps Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Neuromodulation Devices and Implantable Infusion Pumps in China Market
Table 2. Top Neuromodulation Devices and Implantable Infusion Pumps Players in China Market, Ranking by Revenue (2019)
Table 3. China Neuromodulation Devices and Implantable Infusion Pumps Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Companies, 2016-2021
Table 5. China Neuromodulation Devices and Implantable Infusion Pumps Sales by Companies, (Unit), 2016-2021
Table 6. China Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Neuromodulation Devices and Implantable Infusion Pumps Product Type
Table 9. List of Tier 1 Neuromodulation Devices and Implantable Infusion Pumps Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Neuromodulation Devices and Implantable Infusion Pumps Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Spinal Cord Stimulation
Table 12. Major Manufacturers of Deep Brain Stimulation
Table 13. By Type - China Neuromodulation Devices and Implantable Infusion Pumps Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), 2016-2021
Table 17. By Type - China Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), 2022-2027
Table 18. By Application - China Neuromodulation Devices and Implantable Infusion Pumps Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), 2016-2021
Table 22. By Application - China Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), 2022-2027
Table 23. Medtronic Corporation Information
Table 24. Medtronic Description and Major Businesses
Table 25. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product
Table 27. Medtronic Recent Developments
Table 28. Boston Scientific Corporation Corporation Information
Table 29. Boston Scientific Corporation Description and Major Businesses
Table 30. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product
Table 32. Boston Scientific Corporation Recent Developments
Table 33. St. Jude Medical Corporation Information
Table 34. St. Jude Medical Description and Major Businesses
Table 35. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 37. St. Jude Medical Recent Developments
Table 38. Synapse Biomedical Corporation Information
Table 39. Synapse Biomedical Description and Major Businesses
Table 40. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 42. Synapse Biomedical Recent Developments
Table 43. Nevro Corporation Corporation Information
Table 44. Nevro Corporation Description and Major Businesses
Table 45. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product
Table 47. Nevro Corporation Recent Developments
Table 48. Neuropace Corporation Information
Table 49. Neuropace Description and Major Businesses
Table 50. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product
Table 52. Neuropace Recent Developments
Table 53. Cyberonics Corporation Information
Table 54. Cyberonics Description and Major Businesses
Table 55. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product
Table 57. Cyberonics Recent Developments
Table 58. Autonomic Technologies Corporation Information
Table 59. Autonomic Technologies Description and Major Businesses
Table 60. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product
Table 62. Autonomic Technologies Recent Developments
Table 63. Avery Biomedical Corporation Information
Table 64. Avery Biomedical Description and Major Businesses
Table 65. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 67. Avery Biomedical Recent Developments
Table 68. Greatbatch Medical Corporation Information
Table 69. Greatbatch Medical Description and Major Businesses
Table 70. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product
Table 72. Greatbatch Medical Recent Developments
Table 73. Neuromodulation Devices and Implantable Infusion Pumps Production Capacity (Unit) of Key Manufacturers in China Market, 2019-2021 (Unit)
Table 74. China Neuromodulation Devices and Implantable Infusion Pumps Capacity Market Share of Key Manufacturers, 2019-2021
Table 75. Neuromodulation Devices and Implantable Infusion Pumps Market Opportunities & Trends in China Market
Table 76. Neuromodulation Devices and Implantable Infusion Pumps Market Drivers in China Market
Table 77. Neuromodulation Devices and Implantable Infusion Pumps Market Restraints in China Market
Table 78. Neuromodulation Devices and Implantable Infusion Pumps Raw Materials
Table 79. Neuromodulation Devices and Implantable Infusion Pumps Raw Materials Suppliers in China Market
Table 80. Typical Neuromodulation Devices and Implantable Infusion Pumps Downstream
Table 81. Neuromodulation Devices and Implantable Infusion Pumps Downstream Clients in China Market
Table 82. Neuromodulation Devices and Implantable Infusion Pumps Distributors and Sales Agents in China Market
List of FiguresFigure 1. Neuromodulation Devices and Implantable Infusion Pumps Product Picture
Figure 2. Neuromodulation Devices and Implantable Infusion Pumps Segment by Type
Figure 3. Neuromodulation Devices and Implantable Infusion Pumps Segment by Application
Figure 4. China Neuromodulation Devices and Implantable Infusion Pumps Market Overview: 2020
Figure 5. China Neuromodulation Devices and Implantable Infusion Pumps Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Neuromodulation Devices and Implantable Infusion Pumps Revenue, 2016-2027 (US$, Mn)
Figure 7. Neuromodulation Devices and Implantable Infusion Pumps Sales in China Market: 2016-2027 (Unit)
Figure 8. The Top 3 and 5 Players Market Share by Neuromodulation Devices and Implantable Infusion Pumps Revenue in 2020
Figure 9. Spinal Cord Stimulation Product Picture
Figure 10. Deep Brain Stimulation Product Picture
Figure 11. Sacral Nerve Stimulation Product Picture
Figure 12. Vagal Nerve Stimulation Product Picture
Figure 13. Gastric Stimulation Product Picture
Figure 14. By Type - China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share, 2016-2027
Figure 15. By Type - China Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share, 2016-2027
Figure 16. By Type - China Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit), 2016-2027
Figure 17. Parkinson's Disease
Figure 18. Epilepsy
Figure 19. Pain
Figure 20. Other
Figure 21. By Application - China Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share, 2016-2027
Figure 22. By Application - China Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share, 2016-2027
Figure 23. By Application - China Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit), 2016-2027
Figure 24. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. China Neuromodulation Devices and Implantable Infusion Pumps Production Capacity (Unit), 2016-2027
Figure 35. Neuromodulation Devices and Implantable Infusion Pumps Industry Value Chain
Figure 36. Marketing Channels